Tech Transfer team secures funding for developing a new porous titanium implant in collaboration with AMES Medical.

Prof. José María Manero and the Technology Transfer team, in collaboration with AMES Medical, has been
awarded funding from the Indústria del Coneixement 2025 program to develop their project "TiOBA: Titanium Osteointegration and Bacterial Activity".

The project focuses on the development of porous titanium implants with a nanotexture obtained through a chemical process known as nanocavitation. This surface treatment provides a dual benefit:

• Enhanced osteointegration (happens when an implant bonds directly with the bone), by promoting bone cell adhesion, proliferation and mineralization.
• Antibacterial activity, by preventing bacterial colonization and reducing the risk of post-surgical infections.

This innovation addresses two of the main challenges in orthopedic and trauma implants: the need for faster, more effective bone integration, and the growing threat of antibiotic-resistant infections.

Once again, the university-industry alliance proves to be key to bringing innovation from the laboratory to the patient.